Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.

Ophthalmic genetics - 1 Jan 2000

Kuhli-Hattenbach Claudia, Hellstern Peter, Nägler Dorit Karin, Kohnen Thomas, Hattenbach Lars-Olof

Abstract excerpt

BACKGROUND: Thus far, no data has become available to evaluate systematically the prevalences of prothrombin polymorphism A19911G (PT A19911G), factor V HR2 haplotype A4070G (FV A4070G), or plasminogen activator-inhibitor-1 polymorphism 4G/5G (PAI-1 4G/5G) in patients who develop retinal vein occlusion (RVO) without cardiovascular risk factors. MATERIALS AND METHODS: We retrospectively evaluated comprehensive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Factor V
Share to Gene Frequency

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Haplotypes

Share to Plasminogen Activator Inhibitor 1

Share to Prevalence

Share to Prothrombin

Share to Retinal Vein Occlusion

Share to Thrombophilia

Source

Identifiers

PMID: 28085526
DOI: 10.1080/13816810.2016.1244694

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.PMID 28085526Read ↗

Thrombophilic mutations as risk factor for retinal vein occlusion: a case-control study.Semantic proximity Read ↗

Genetic polymorphisms associated with retinal vein occlusion: a Greek case-control study and meta-analysis.Semantic proximity Read ↗

Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients.Semantic proximity Read ↗

Thrombophilic mutations and risk of retinal vein occlusion.Semantic proximity Read ↗

Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age.Semantic proximity Read ↗

Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusionSemantic proximity Read ↗

Retinal vein occlusion: genetic predisposition and systemic risk factors.Semantic proximity Read ↗

The heterozygous 20210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion: a pilot study.Semantic proximity Read ↗

Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels.Semantic proximity Read ↗

PON1, APOE and SDF-1 Gene Polymorphisms and Risk of Retinal Vein Occlusion: A Case-Control Study.Semantic proximity Read ↗

Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors.Semantic proximity Read ↗

Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.